retatrutide phase 2 nejm weight loss 48 weeks percent 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No plateau — curve still descending This week's most cited articles:

[DOI] [PubMed] [Google Scholar] Yaney GC, Korchak HM, Corkey BE

This allows compounding pharmacies to get in the game

The difference between a full therapeutic dose and a microdose of GLP-1 medication comes down to how much you take and what the goal is

Taken together, these data suggest that glucagon receptor blockade results in an extreme increase in serum glutamine and alanine

Supplementing early is a proactive way to maintain the structural integrity and cellular health you had in your younger years

John Macleod, a skeptical but supportive professor at the University of Toronto, provided lab space and paired Banting with Charles Best, a bright and eager medical student